Skip to content
Catalyst

fucoidanFinding

Fucoidan decreases serum creatinine concentration

lowersModerate evidenceFinding

01 · The sentence it was drawn from

“The changes in creatinine (Cre) at the 12th week (−0.1 ± 0.3) and 24th week (−0.2 ± 0.4) during oligo-fucoidan supplementation decreased more significantly than those in the control group at the 12th week (0.03 ± 0.07) and 24th week (0.07 ± 0.06) (p = 0.012 and p = 0.008).”
Quoted verbatim from Effects of oligo-fucoidan on the immune response, inflammatory status and pulmonary function in patients with asthma: a randomized, double-blind, placebo-controlled trial.
This finding among the 20 findings on its endpoint

fucoidan

Serum creatinine concentration

lowers

Who
Twenty adults with allergic asthma; both arms received regular asthma treatment; change from baseline at 12 and 24 weeks
Dose studied
550 mg x 4 tablets per time, twice a day, 24 weeks, oral

Moderate evidencePMID 36307493 · 2022

02 · The study

Study
RCT
Duration
6 months

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7FQFBD8PDYWK6EF1A3P64N8